Papaverine and Stereotactic Body Radiotherapy (SBRT) for Non Small Cell Lung Cancer (NSCLC) or Lung Metastases
Clinical trial NCT03824327 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03824327
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-07
- Primary completion
- 2026-08-31
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.